Return to homepagePandemic Pact

to evaluate breadth and duration of protection conferred by OVX836 against seasonal and highly pathogenic influenza strains, informing its potential as a vaccine for long-term prevention of seasonal and pandemic influenza

Grant number: INV-051738

Grant search

Key facts

  • Disease

    Unspecified

  • Start & end year

    2023

  • Known Financial Commitments (USD)

    $1,124,202

  • Funder

    Gates Foundation

  • Research Location

    France

  • Lead Research Institution

    Osivax

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Characterisation of vaccine-induced immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A